Edition:
United States

Dr.Reddy's Laboratories Ltd (REDY.NS)

REDY.NS on National Stock Exchange of India

2,616.25INR
24 Sep 2018
Change (% chg)

Rs54.65 (+2.13%)
Prev Close
Rs2,561.60
Open
Rs2,570.60
Day's High
Rs2,619.25
Day's Low
Rs2,550.25
Volume
759,251
Avg. Vol
1,057,985
52-wk High
Rs2,670.80
52-wk Low
Rs1,887.00

Latest Key Developments (Source: Significant Developments)

Dr.Reddy's Laboratories Says Unit Filed Lawsuit Against Perrigo UK Finco, Perrigo Israel Pharma, Taro Pharmaceuticals
Friday, 25 May 2018 08:35am EDT 

May 25 (Reuters) - Dr.Reddy's Laboratories Ltd ::UNIT PROMIUS PHARMA FILED LAWSUIT FOR PATENT INFRINGEMENT IN U.S. COURT.FILED LAWSUIT AGAINST PERRIGO UK FINCO, PERRIGO ISRAEL PHARMACEUTICALS, AND TARO PHARMACEUTICALS.LAWSUIT FILED IN RESPONSE TO NOTICE LETTERS RECEIVED FOR TOPICAL SPRAY SERNIVO PRODUCT.UNIT ANTICIPATES LAWSUIT WILL TRIGGER A 30 MONTH STAY OF FDA APPROVAL OF PERRIGO'S AND TARO'S ANDAS.  Full Article

Dr.Reddy's Laboratories Gets EIR From US FDA For API Cuernavaca Plant In Mexico
Tuesday, 10 Apr 2018 02:06am EDT 

April 10 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS GETS EIR FROM US FDA FOR API CUERNAVACA PLANT IN MEXICO.  Full Article

Dr.Reddy's Labs' U.S. Unit Announces ANDA Filing For Migraine Candidate
Monday, 2 Apr 2018 05:43am EDT 

April 2 (Reuters) - Dr.Reddy's Laboratories Ltd ::CO, U.S. UNIT PROMIUS PHARMA ANNOUNCE FILING OF AN NDA FOR MIGRAINE CANDIDATE.UPON APPROVAL, PRODUCT WILL BE COMMERCIALISED BY PROMIUS PHARMA.  Full Article

Dr.Reddy's Laboratories Appoints Erez Israeli As Chief Operating Officer
Thursday, 29 Mar 2018 01:03am EDT 

March 29 (Reuters) - Dr.Reddy's Laboratories Ltd ::CHIEF OPERATING OFFICER ABHIJIT MUKHERJEE TO RETIRE ON MARCH 31.APPOINTS EREZ ISRAELI AS CHIEF OPERATING OFFICER.  Full Article

Dr.Reddy's Labs Gets Form 483 With 4 Observations For API Hyderabad Plant Audit
Friday, 16 Mar 2018 05:36am EDT 

March 16 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS AUDIT OF API HYDERABAD PLANT IN TELENGANA BY U.S. FDA COMPLETED ON MARCH 16.SAYS CO BEEN ISSUED ONE FORM 483 WITH 4 OBSERVATIONS.  Full Article

Dr.Reddy's Laboratories Launches Levocetirizine Dihydrochloride Tablets USP, 5 Mg In U.S.
Friday, 16 Mar 2018 01:58am EDT 

March 16 (Reuters) - Dr.Reddy's Laboratories Ltd ::ANNOUNCES LAUNCH OF LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS USP, 5 MG IN U.S. MARKET.  Full Article

India's Dr.Reddy's Laboratories Gets 5 Observations From U.S FDA For API Unit At Hyderabad ‍​
Friday, 9 Mar 2018 04:53am EST 

March 9 (Reuters) - Dr.Reddy's Laboratories Ltd ::U.S FDA ISSUES FORM 483 WITH 5 OBSERVATIONS FOR API UNIT AT HYDERABAD ‍​.  Full Article

Dr.Reddy's Laboratories Says Amended Complaint w.r.t U.S. Class Action Lawsuit Filed
Monday, 19 Feb 2018 01:33am EST 

Feb 19 (Reuters) - Dr.Reddy's Laboratories Ltd ::W.R.T U.S. CLASS ACTION LAWSUIT, AMENDED COMPLAINT FILED BY PLAINTIFF WHERE CHAIRMAN, COO AND U.S. UNIT ADDED AS DEFENDANTS.  Full Article

Dr.Reddy's Lab Announces Launch Of Tetrabenazine Tablets In U.S. Market
Friday, 2 Feb 2018 12:59am EST 

Feb 2 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS ANNOUNCEMENT OF LAUNCH OF TETRABENAZINE TABLETS IN U.S. MARKET.  Full Article

India's Dr.Reddy's Laboratories Dec-Qtr Consol Net PAT Falls 38.5 Pct
Thursday, 25 Jan 2018 01:31am EST 

Jan 25 (Reuters) - Dr.Reddy's Laboratories Ltd ::DEC QUARTER CONSOL NET PROFIT AFTER TAX 3.03 BILLION RUPEES VERSUS PROFIT OF 4.92 BILLION RUPEES LAST YEAR.DEC QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 38.34 BILLION RUPEES VERSUS 37.23 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR DEC QUARTER CONSOL PROFIT WAS 3.40 BILLION RUPEES.  Full Article

Indivior: U.S. court rules against generic rival's appeal

Indivior Plc notched a legal victory on Tuesday after a U.S. court reaffirmed that a generic rival could not re-launch cheaper versions of the British drugmaker's best-selling opioid addiction treatment in the United States.